DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I

Article Properties
  • Language
    English
  • Publication Date
    2007/12/01
  • Indian UGC (journal)
  • Citations
    55
  • Marie-Luise Sautter-Bihl
  • Wilfried Budach
  • Jürgen Dunst
  • Petra Feyer
  • Wulf Haase
  • Wolfgang Harms
  • Felix Sedlmayer
  • Rainer Souchon
  • Frederik Wenz
  • Rolf Sauer
Cite
Sautter-Bihl, Marie-Luise, et al. “DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I”. Strahlentherapie Und Onkologie, vol. 183, no. 12, 2007, pp. 661-6, https://doi.org/10.1007/s00066-007-1811-1.
Sautter-Bihl, M.-L., Budach, W., Dunst, J., Feyer, P., Haase, W., Harms, W., Sedlmayer, F., Souchon, R., Wenz, F., & Sauer, R. (2007). DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I. Strahlentherapie Und Onkologie, 183(12), 661-666. https://doi.org/10.1007/s00066-007-1811-1
Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Haase W, Harms W, et al. DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I. Strahlentherapie und Onkologie. 2007;183(12):661-6.
Citations
Title Journal Journal Categories Citations Publication Date
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial International Journal of Radiation Oncology*Biology*Physics
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
2 2023
Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis

Strahlentherapie und Onkologie
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
15 2021
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial) International Journal of Radiation Oncology*Biology*Physics
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
30 2021
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial Radiotherapy and Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
7 2021
Role of miRNAs in regulating responses to radiotherapy in human breast cancer International Journal of Radiation Biology
  • Science: Biology (General)
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Nuclear engineering. Atomic power
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
8 2021
Citations Analysis
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 44 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled El refuerzo de radioterapia después de cirugía conservadora en cáncer de mama localmente avanzado and was published in 2009. The most recent citation comes from a 2023 study titled Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial. This article reached its peak citation in 2009, with 18 citations. It has been cited in 25 different journals, 16% of which are open access. Among related journals, the Strahlentherapie und Onkologie cited this research the most, with 26 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year